International Journal of Clinical Pharmacy

Papers
(The H4-Index of International Journal of Clinical Pharmacy is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
The International Collaboration of Pharmacy Journal Editors (ICPJE) formally constituted to foster quality around clinical and social pharmacy practice research publications*68
Investigating the controversy surrounding statin therapy and Achilles tendinopathy using Mendelian randomization analysis59
Medication changes and potentially inappropriate prescribing in older patients with significant polypharmacy57
ESCP International Workshop: Pharmacotherapy challenges in the developing years: from conception to adolescence 24–25 April 2024, Bratislava, Slovakia46
A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country34
Evaluation of rivaroxaban-, apixaban- and dabigatran-associated hemorrhagic events using the FDA-Adverse event reporting system (FAERS) database34
Clinical pharmacist consultant in primary care settings in Slovenia focused on elderly patients on polypharmacy: successful national program from development to reimbursement32
European Society of Clinical Pharmacy: ‘Implementing and scaling sustainable clinical pharmacy’31
Impact of pharmacist-involved collaborative care on diabetes management in a primary healthcare setting using real-world data27
Determination of potential drug–drug interactions in prescription orders dispensed in a community pharmacy setting using Micromedex® and Lexicomp®: a retrospective observational study27
Author Correction to: Prolonged oxycodone use and potential risk factors in postoperative patients: a case control study26
Developing and piloting a communication assessment tool assessing patient perspectives on communication with pharmacists (CAT-Pharm)26
Contextual factors influencing medicines-related interventions to support safe transitions for care home residents post hospital discharge: a systematic review and meta-ethnographic synthesis25
Correlation between the number of patient-reported adverse events, adverse drug events, and quality of life in older patients: an observational study25
Survey on general practitioners’ and pharmacists’ opinions regarding patient-initiated treatment of recurring urinary tract infections24
Regulating pediatric off-label uses of medicines in the EU and USA: challenges and potential solutions24
Efficacy and safety of metformin compared to insulin in gestational diabetes: a systematic review and meta-analysis of Chinese randomized controlled trials23
Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children22
Lithium surveillance by community pharmacists and physicians in ambulatory patients: a retrospective cohort study22
A systematic review of quantitative studies exploring staff views on antipsychotic use in residents with dementia in care homes22
A qualitative exploration of the enablers and barriers to the provision of outpatient clinics by hospital pharmacists21
Identification and evaluation of medication-related issues relating to patient’s own drugs by pharmacy students while on placement in a tertiary hospital21
0.05820107460022